Literature DB >> 29396319

Oral potentially malignant disorders: risk of progression to malignancy.

Paul M Speight1, Syed Ali Khurram2, Omar Kujan3.   

Abstract

Oral potentially malignant disorders (OPMDs) have a statistically increased risk of progressing to cancer, but the risk varies according to a range of patient- or lesion-related factors. It is difficult to predict the risk of progression in any individual patient, and the clinician must make a judgment based on assessment of each case. The most commonly encountered OPMD is leukoplakia, but others, including lichen planus, oral submucous fibrosis, and erythroplakia, may also be seen. Factors associated with an increased risk of malignant transformation include sex; site and type of lesion; habits, such as smoking and alcohol consumption; and the presence of epithelial dysplasia on histologic examination. In this review, we attempt to identify important risk factors and present a simple algorithm that can be used as a guide for risk assessment at each stage of the clinical evaluation of a patient.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29396319     DOI: 10.1016/j.oooo.2017.12.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  78 in total

Review 1.  Oral Epithelial Dysplasia and Premalignancy.

Authors:  Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2019-03-18

2.  Cues used by dentists in the early detection of oral cancer and oral potentially malignant lesions: findings from the National Dental Practice-Based Research Network.

Authors:  Alexander Ross Kerr; Michael E Robinson; Cyril Meyerowitz; Douglas E Morse; Maria L Aguilar; Scott L Tomar; Lisa Guerrero; Dianne Caprio; Linda M Kaste; Sonia K Makhija; Rahma Mungia; Linda Rasubala; Walter J Psoter
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2020-05-23

3.  World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.

Authors:  Alessandro Villa; Antonio Celentano; Ingrid Glurich; Wenche S Borgnakke; Siri Beier Jensen; Douglas E Peterson; Konstantina Delli; David Ojeda; Arjan Vissink; Camile S Farah
Journal:  Oral Dis       Date:  2019-06       Impact factor: 3.511

4.  Genetic polymorphism of tumor necrosis factor alpha (TNF-α) and tumor necrosis factor beta (TNF-β) genes and risk of oral pre-cancer and cancer in North Indian population.

Authors:  Shalini Gupta; Kumud Nigam; Ratnesh Kumar Srivastav; Md Kaleem Ahmad; Abbas Ali Mahdi; Somali Sanyal
Journal:  Oral Maxillofac Surg       Date:  2021-03-29

Review 5.  Screening for mouth cancer: the pros and cons of a national programme.

Authors:  P R Brocklehurst; P M Speight
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

6.  Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.

Authors:  Hans Prakash Sathasivam; Ralf Kist; Syed Haider; Max Robinson; Philip Sloan; Peter Thomson; Michael Nugent; John Alexander
Journal:  Br J Cancer       Date:  2021-05-10       Impact factor: 7.640

7.  Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.

Authors:  Yin-Ling Wong; Ramanathan Anand; Kar Mun Yuen; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Zainal Ariff Abdul Rahman; Yeng Chen
Journal:  Glycoconj J       Date:  2021-02-06       Impact factor: 2.916

8.  Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Han Yang; Cheng-Ming Luo; Pei-Wen Wu
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

9.  Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis.

Authors:  Maria Georgaki; Dimitris Avgoustidis; Vasileios Ionas Theofilou; Evangelia Piperi; Efstathios Pettas; Demos G Kalyvas; Dimitrios Vlachodimitropoulos; Christos Perisanidis; Andreas C Lazaris; Nikolaos G Nikitakis
Journal:  Diagnostics (Basel)       Date:  2021-05-12

Review 10.  Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jagadish Hosmani; Shazia Mushtaq; Shahabe Saquib Abullais; Hussain Mohammed Almubarak; Khalil Assiri; Luca Testarelli; Alessandro Mazzoni; Shankargouda Patil
Journal:  Medicina (Kaunas)       Date:  2021-05-01       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.